Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
CBC GROUP AND MUBADALA CO-LEAD US$315 MILLION FUNDRAISING ROUND FOR HASTEN BIOPHARMA 2023-04-20 13:00
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023 2023-04-20 08:00
Innovent Announces Overall Survival Results of Phase 2 Study of Pemazyre® (pemigatinib) in Chinese Patients with Advanced Cholangiocarcinoma Presented at AACR Annual Meeting 2023 2023-04-20 08:00
Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line 2023-04-19 20:05
Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses 2023-04-19 08:45
AACR 2023 | ImmVira presented preclinical study results of first CAR-T enabler oncolytic product MVR-T7011 at AACR Annual Meeting 2023-04-19 08:29
Bridge Biotherapeutics Releases Updated Preclinical Data for BBT-207 at the AACR Annual Meeting 2023-04-19 07:00
Technoderma Medicines Initiates TDM-105795 Androgenetic Alopecia Phase 2 Clinical Trial 2023-04-18 21:00
South Korean Biotech, ToolGen Leads the Development of Numerous Cutting-Edge Genome Editing Techniques 2023-04-18 21:00
Biosyngen announces FDA IND approval of its second product for EBV-positive lymphoma 2023-04-18 19:03
YS Biopharma Announces Record Vaccine Revenues and Preliminary Financial Results for FY2023 Ended March 31, 2023 2023-04-18 19:00
Daewoong Pharmaceutical and Sygnature Discovery announce drug discovery research collaboration 2023-04-18 17:16
GC Biopharma celebrates 'World Hemophilia Day' 2023-04-18 09:03
Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023 2023-04-18 08:00
Innovent Releases Final Analysis Results of ORIENT-16: the Phase 3 Study of Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric Cancer at the AACR Annual Meeting 2023 2023-04-18 08:00
Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic Kidney Disease 2023-04-18 08:00
Innovent Announces Updated Data of Phase 1 Clinical Trial for IBI351 (KRAS[G12C] Inhibitor) as Monotherapy for Solid Tumors at the AACR Annual Meeting 2023 2023-04-18 08:00
Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting 2023-04-18 04:15
Promising Efficacy of AT101 CAR-T for Blood Cancer 2023-04-18 02:00
EXCHANGE OFFER DECLARED UNCONDITIONAL 2023-04-18 01:51
1 113 114 115 116 117 453